Search Browse Earnings

TFF Pharmaceuticals, Inc. — SlamSEC

TFF Pharmaceuticals, Inc.

Pharmaceutical Preparations·AUSTIN, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$495,805

+462.4% YoY

FY 2023

Adj. EBITDA

-$31.4M

-6334.9% margin

FY 2023

Net Income

-$31.8M

-6407.8% margin

FY 2023

EPS (Diluted)

-$26.49

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$16.6M

FY 2023

Total Debt

—

Net Cash

$16.6M

FY 2023

Enterprise Value

—

Debt / EBITDA

0.5x

FY 2023

EV / EBITDA

—

Employees

—

CEO

Weisman Harlan F

CFO

Coleman Kirk Allen